Intelligence · Patents
Patents expiring in 2030
Annual patent cliff calendar for 2030 — US pharmaceutical patents by expiration date.
- Patents
- 905
Quick answer
905 indexed pharmaceutical patents have expiration dates in 2030. Browse by soonest expiry with links to assignee companies and related drugs.
-
US 7741091
Methods of producing hyaluronic acid and chimeric and hybrid glycosaminoglycan polymers
granted -
US 7740867
Method for identification of virulence determinants
granted -
US 7740889
Bacteriocins and novel bacterial strains
granted -
US 7741321
Modulators of ATP-binding cassette transporters
granted -
US 7741304
Casein kinase 2 antisense therapy
granted -
US 7741437
P. ariasi polypeptides, p. perniciosus polypeptides and methods of use
granted -
US 7741063
Toxoplasma gondii oocyst protein
granted -
US 7741113
Cell-specific molecule and method for importing DNA into osteoblast nuclei
granted -
US 7744931
Methods for treating oral cancers with herbal compositions
granted -
US 7745629
Bicyclic derivatives as modulators of ion channels
granted -
US 7745608
Modified iRNA agents
granted -
US 7745444
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
granted -
US 7745409
Methods and compositions for the treatment of gastrointestinal disorders
granted -
US 7745144
Peptides and their utility in modulation of behavior of cells expressing α3β1 integrins
granted -
US 7745468
Compounds for treatment of cell proliferative diseases
granted -
US 7745489
Compositions and methods for inhibition of phospholipase A2 mediated inflammation
granted -
US 7745407
Competitive regulation of hepcidin mRNA by soluble and cell-associated hemojuvelin
granted -
US 7745623
Cyclic amide derivative, and its production and use
granted -
US 7744851
Methods and agents for preparing 18F-radiolabeled fluorinating agents
granted -
US 7744861
Multi-arm polymer prodrugs
granted -
US 7744934
Methods for modulating eicosanoid metabolism
granted -
US 7745388
Peptides for activation and inhibition of δPKC
granted -
US 7744902
Respiratory syncytial virus vaccines expressing protective antigens from promotor-proximal genes
granted -
US 7745406
Fibroblast growth factor (FGF23) polypeptides
granted -
US 7745212
Melanoma antigens and their use in diagnostic and therapeutic methods
granted -
US 7745416
Method for in vivo regulation of cardiac muscle contractility
granted -
US 7745401
Antifungal peptides and methods of use thereof
granted -
US 7745418
Compositions and methods for inhibiting viral replication
granted -
US 7745569
Amyloid specific binding peptides and detecting abeta peptide
granted -
US 7745708
Self-assembly of peptide-amphiphile nanofibers under physiological conditions
granted -
US 7745691
Genetically modified mouse lacking diacylglycerol acyltransferase-1 (DGAT-1) activity
granted -
EP 2201950
Verbindungen und Verfahren zur Behandlung von autistischen Spektrumsstörungen
granted -
US 7749536
Pharmaceutical formulations of aliphatic amine polymers and methods for their manufacture
granted -
US 7749694
C-type lectin fold as a scaffold for massive sequence variation
granted -
US 7749510
Methods of eliciting or boosting a cellular immune response
granted -
US 7749978
Compositions and methods for inhibiting expression of Huntingtin gene
granted -
US 7750037
Antidepressant
granted -
US 7749984
Computer-based model for identification and characterization of non-competitive inhibitors of nicotinic acetylcholine receptors and related ligand-gated ion channel receptors
granted -
US 7749967
Peptides of a melanoma antigen and their use in diagnostic, prophylactic, and therapeutic methods
granted -
US 7749720
Methods of identifying compounds for producing insulin sensitization
granted -
US 7749719
Melanoma antigens and their use in diagnostic and therapeutic methods
granted -
US 7749532
Once daily formulations of tetracyclines
granted -
US 7749490
Mutant IL-10
granted -
US 7750023
Quinuclidine derivatives and medicinal compositions containing the same
granted -
US 7749983
Metabolically stable alkoxyalkyl esters of antiviral or antiproliferative phosphonates, nucleoside phosphonates and nucleoside phosphates
granted -
US 7750051
Crystalline solid rasagiline base
granted -
US 7749545
Fucoidan compositions and methods for dietary and nutritional supplements
granted -
US 7750120
Modified vitamin K-dependent polypeptides
granted
Frequently asked questions
How many pharma patents expire in 2030?
905 published patents in our USPTO index have expiration dates falling in calendar year 2030.